C. Debruyne
Impact in
- Pulmonary and Respiratory Medicine top 0.5%
- Lung Cancer Treatments and Mutations
- Lung Cancer Diagnosis and Treatment
- Occupational and environmental lung diseases
- Pleural and Pulmonary Diseases
- Brain Metastases and Treatment
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
- Genetics top 1%
- Glioma Diagnosis and Treatment
Papers in
- Oncology 28
- Lung Cancer Research Studies 16
- Cancer Immunotherapy and Biomarkers 7
-
- Lung Cancer Treatments and Mutations 14
- Occupational and environmental lung diseases 9
- Lung Cancer Diagnosis and Treatment 7
- Pleural and Pulmonary Diseases 4
- Co-authors
- Giuseppe Giaccone (33 shared papers)Jan P. van Meerbeeck (16 shared papers)Egbert F. Smit (8 shared papers)Bonne Biesma (9 shared papers)Rabab Gaafar (7 shared papers)Desmond Curran (4 shared papers)Franz M.N.H. Schramel (5 shared papers)Nico van Zandwijk (9 shared papers)
- Journals
- Journal of Clinical Oncology (15 papers)European Journal of Cancer (8 papers)Lung Cancer (5 papers)Annals of Oncology (5 papers)Cancer (2 papers)
- Partner nations
- NetherlandsBelgiumItaly
In The Last Decade
C. Debruyne
47 papers receiving 3.6k citations
C. Debruyne's Hit Papers
Peers
Comparison fields: 5 of 93
- Pulmonary and Respiratory Medicine 2.1k
- Genetics 606
- Oncology 1.2k
- Cancer Research 181
- Radiology, Nuclear Medicine and Imaging 272
Countries citing papers authored by C. Debruyne
This map shows the geographic impact of C. Debruyne's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C. Debruyne with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C. Debruyne more than expected).
Fields of papers citing papers by C. Debruyne
This network shows the impact of papers produced by C. Debruyne. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C. Debruyne. The network helps show where C. Debruyne may publish in the future.
Co-authors
The 25 scholars most cited alongside C. Debruyne, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 49 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Prognostic Factors for Survival in Adult Patients With Cerebral Low-Grade Glioma Hit paper breakdown → | 2002 | 661 |
| 2 | Randomized Phase III Study of Cisplatin With or Without Raltitrexed in Patients With Malignant Pleural Mesothelioma: An Intergroup Study of the European Organisation for Research and Treatment of Cancer Lung Cancer Group and the National Cancer Institute of Canada Hit paper breakdown → | 2005 | 476 |
| 3 | Randomized Controlled Trial of Resection Versus Radiotherapy After Induction Chemotherapy in Stage IIIA-N2 Non-Small-Cell Lung Cancer Hit paper breakdown → | 2007 | 474 |
| 4 | 2003 | 280 | |
| 5 | 1998 | 229 | |
| 6 | 2002 | 192 | |
| 7 | 2005 | 169 | |
| 8 | 2006 | 152 | |
| 9 | 2000 | 113 | |
| 10 | 1999 | 107 | |
| 11 | 2003 | 82 | |
| 12 | 2001 | 79 | |
| 13 | 2002 | 75 | |
| 14 | 1996 | 66 | |
| 15 | 1999 | 64 | |
| 16 | European organization for research and treatment of cancer (EORTC) 08957 phase II study of topotecan in combination with cisplatin as second-line treatment of refractory and sensitive small cell lung cancer. | 2003 | 62 |
| 17 | 2003 | 46 | |
| 18 | 2003 | 46 | |
| 19 | 2014 | 38 | |
| 20 | 2008 | 31 |
About C. Debruyne
C. Debruyne is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Surgery, Molecular Biology and Neurology, having authored 49 papers that have together received 3.7k indexed citations. Recurring topics across this work include Lung Cancer Research Studies (16 papers), Lung Cancer Treatments and Mutations (14 papers), Occupational and environmental lung diseases (9 papers), Cancer Immunotherapy and Biomarkers (7 papers), Lung Cancer Diagnosis and Treatment (7 papers), Neuroblastoma Research and Treatments (4 papers), Pleural and Pulmonary Diseases (4 papers) and Glycosylation and Glycoproteins Research (3 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (2.1k citations), Genetics (606 citations), Oncology (1.2k citations), Cancer Research (181 citations) and Radiology, Nuclear Medicine and Imaging (272 citations). C. Debruyne has collaborated with scholars based in Netherlands, Belgium and Italy. Frequent co-authors include Giuseppe Giaccone, Jan P. van Meerbeeck, Egbert F. Smit, Bonne Biesma, Rabab Gaafar, Desmond Curran, Franz M.N.H. Schramel, Nico van Zandwijk, Catherine Legrand and Eric A. Van Marck. Their work appears in journals such as Journal of Clinical Oncology, European Journal of Cancer, Lung Cancer, Annals of Oncology and Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.